Salix files NDA for diarrhea drug despite dispute with partner Napo
Gastrointestinal therapeutics firm Salix Pharmaceuticals (NASDAQ:SLXP) is pressing ahead with a drug candidate to treat diarrhea in AIDS patients despite a deteriorating relationship with its drug partner that has led to a contract dispute and dueling lawsuits. Raleigh, North Carolina-based Salix today filed a New Drug Application for crofelemer, a filing that comes more than […]